Log in to save to my catalogue

Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure

Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727082224

Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure

About this item

Full title

Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2022-10

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Cardiac fibrosis is causally linked to heart failure pathogenesis and adverse clinical outcomes. However, the precise fibroblast populations that drive fibrosis in the human heart and the mechanisms that govern their emergence remain incompletely defined. Here, we performed Cellular Indexing of Transcriptomes and Epitomes by sequencing (CITE-seq) i...

Alternative Titles

Full title

Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2727082224

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727082224

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2022.10.17.512579